165 related articles for article (PubMed ID: 37351807)
21. Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among Koreans.
Ko YH; Ree HJ; Kim WS; Choi WH; Moon WS; Kim SW
Cancer; 2000 Nov; 89(10):2106-16. PubMed ID: 11066052
[TBL] [Abstract][Full Text] [Related]
22. The Clinical Features and Survival Outcome of 107 Newly Diagnosed Advanced Stage Extranodal NK/T-Cell Lymphoma Cases: A Triple-Center Study.
Li J; Li J; Zhong M; Zhou H; Yu B
Cancer Manag Res; 2021; 13():1541-1549. PubMed ID: 33623433
[TBL] [Abstract][Full Text] [Related]
23. [(18)F-FDG PET/CT for extranodular natural killer/T-cell lymphoma nasal type: imaging findings and clinical value].
Song JH; Qiao WL; Chen X; Liu CC; Xing Y; Wang TS; Zhao JH
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Aug; 36(8):1123-8. PubMed ID: 27578584
[TBL] [Abstract][Full Text] [Related]
24. Extranodal NK / T-cell lymphoma, nasal type: new staging system and treatment strategies.
Kim TM; Heo DS
Cancer Sci; 2009 Dec; 100(12):2242-8. PubMed ID: 19758393
[TBL] [Abstract][Full Text] [Related]
25. Tumor necrosis and complete resection has significant impacts on survival in patients with limited-stage upper aerodigestive tract NK/T cell lymphoma.
Song MK; Chung JS; Yhim HY; Lim SN; Kim SJ; Han YH; Shim HK; Jung SH; Lee JJ; Yang DH
Oncotarget; 2017 Oct; 8(45):79337-79346. PubMed ID: 29108312
[TBL] [Abstract][Full Text] [Related]
26. PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma.
Bi XW; Wang H; Zhang WW; Wang JH; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Zhang YJ; Wang L
J Hematol Oncol; 2016 Oct; 9(1):109. PubMed ID: 27737703
[TBL] [Abstract][Full Text] [Related]
27. Abnormal pretreatment coagulation factor levels correlate with poor prognosis in patients with early-stage extranodal nasal-type natural/killer T cell lymphoma.
Chai Y; Qi F; Chen B; Gui L; Yang J; Qi S; Song Y; Li Y; Wei Y; Dong M
Ann Hematol; 2020 Jun; 99(6):1303-1309. PubMed ID: 32333152
[TBL] [Abstract][Full Text] [Related]
28. Serum beta2-microglobin is a predictor of prognosis in patients with upper aerodigestive tract NK/T-cell lymphoma.
Li ZM; Zhu YJ; Sun J; Xia Y; Huang JJ; Zou BY; Lin TY; Huang HQ; Jiang WQ
Ann Hematol; 2012 Aug; 91(8):1265-70. PubMed ID: 22373550
[TBL] [Abstract][Full Text] [Related]
29. Survival trends for extranodal NK/T-cell lymphoma, nasal type from different anatomical sites: a population-based study.
He L; Zou Y; Tang X; Wang J; Xing L; Zhang J; Li J; Guo J; Miao Y
Ann Transl Med; 2021 May; 9(10):849. PubMed ID: 34164483
[TBL] [Abstract][Full Text] [Related]
30. Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosis.
Lima M
Orphanet J Rare Dis; 2013 Jul; 8():95. PubMed ID: 23816348
[TBL] [Abstract][Full Text] [Related]
31. Immunophenotypic characteristics and clinical relevance of CD56+ and CD56- extranodal nasal-type natural killer/T-cell lymphoma.
Li YX; Wang H; Feng XL; Liu QF; Wang WH; Lv N; Jin J; Wang SL; Liu YP; Fang H; Song YW; Liu XF; Zhou LQ; Wang ZY; Yu ZH
Leuk Lymphoma; 2011 Mar; 52(3):417-24. PubMed ID: 21323521
[TBL] [Abstract][Full Text] [Related]
32. A prognostic model based on pretreatment platelet lymphocyte ratio for stage IE/IIE upper aerodigestive tract extranodal NK/T cell lymphoma, nasal type.
Wang KF; Chang BY; Chen XQ; Liu PP; Wuxiao ZJ; Wang ZH; Li S; Jiang WQ; Xia ZJ
Med Oncol; 2014 Dec; 31(12):318. PubMed ID: 25377661
[TBL] [Abstract][Full Text] [Related]
33. The clinical characteristics and prognostic factors of 410 patients with natural killer/T-cell lymphoma.
Sun Z; Wan W; Zhang X; Zhang L; Li X; Li L; Wang X; Nan F; Yu H; Chang Y; Yan J; Li Z; Cui F; Ge J; XiaXu YD; Xu X; Fu X; Zhang M
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3449-3459. PubMed ID: 35857124
[TBL] [Abstract][Full Text] [Related]
34. [Pretreatment evaluation of
Peng P; Wu N; Tao XL; Liu Y; Lyu L; Cheng X
Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):370-376. PubMed ID: 35448927
[No Abstract] [Full Text] [Related]
35. Extranodal NK/T-cell lymphoma, nasal type, with extranasal presentation - a case report and a review of the literature.
Akbar M; Clasen-Linde E; Specht L
Acta Oncol; 2020 Dec; 59(12):1480-1487. PubMed ID: 32689856
[TBL] [Abstract][Full Text] [Related]
36. Extranodal natural killer/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors.
Jhuang JY; Chang ST; Weng SF; Pan ST; Chu PY; Hsieh PP; Wei CH; Chou SC; Koo CL; Chen CJ; Hsu JD; Chuang SS
Hum Pathol; 2015 Feb; 46(2):313-21. PubMed ID: 25554090
[TBL] [Abstract][Full Text] [Related]
37. Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study.
Yang Y; Zhu Y; Cao JZ; Zhang YJ; Xu LM; Yuan ZY; Wu JX; Wang W; Wu T; Lu B; Zhu SY; Qian LT; Zhang FQ; Hou XR; Li YX
Blood; 2015 Sep; 126(12):1424-32; quiz 1517. PubMed ID: 26109206
[TBL] [Abstract][Full Text] [Related]
38. The impact of the omission or inadequate dosing of radiotherapy in extranodal natural killer T-cell lymphoma, nasal type, in the United States.
Vargo JA; Patel A; Glaser SM; Balasubramani GK; Farah RJ; Marks SM; Beriwal S
Cancer; 2017 Aug; 123(16):3176-3185. PubMed ID: 28380259
[TBL] [Abstract][Full Text] [Related]
39. The exact Deauville score, NABS score and high SUVmax predicts outcome in extranodal natural killer/T-cell lymphoma.
Huang HL; Ngam PI; Tan KM; Ng DCE; Lim ST; Chan JY
Ann Nucl Med; 2021 May; 35(5):557-568. PubMed ID: 33683545
[TBL] [Abstract][Full Text] [Related]
40. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status.
Ko YH; Cho EY; Kim JE; Lee SS; Huh JR; Chang HK; Yang WI; Kim CW; Kim SW; Ree HJ
Histopathology; 2004 May; 44(5):480-9. PubMed ID: 15139996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]